Vorinostat offers small boost in progression-free survival for multiple myelomaDrug approved for T-cell lymphoma is often prescribed off-label for other hematological disorders Triple therapy for multiple myeloma disappoints in experienced patientsHeavily treated patients had much lower response rate than that seen in other studies Cancer, diabetes link continues to perplex Evidence backing use of metformin as anti-cancer agent doesn’t negate fact that ‘we just don’t know,’ MD says Breast health a taboo topic for many immigrants Some new Canadians see breast cancer as a punishment from God and do not seek out medical care Obesity affects prognosis in esophageal cancer Prolonged fatigue follows breast cancer chemo More data suggest link between high glucose, colorectal cancer risk But researchers have not explained possible causative mechanism Breast cancer drug combo extends progression-free survival Treatment with exemestane and everolimus may signal new approach Brachytherapy disappoints in breast cancer treatment In separate study, MarginProbe device improves results of tumour excision Surgery for advanced breast cancer remains a controversial topic Resection of primary tumour was associated with improved survival in one study, but did not benefit patients in another First Previous 50 51 52 53 54 Next Last
